Table 3.
Comparative study of laboratory data between TGF-β1 − 509 genotypes.
| CC (n = 42) | CT (n = 25) | TT (n = 13) | p-Value | |
|---|---|---|---|---|
| T. bilirubin (mg/dl)a | 0.4 | 0.99 | 1.35 | < 0.05 |
| (0.27–0.68) | (0.43–1.6) | (0.67–3.18) | ||
| a | b | c | ||
| AST (U/L)a | 14 | 27 | 12 | > 0.05 |
| (12–18.5) | (16.5–51) | (10.5–25.5) | ||
| a | a | a | ||
| ALT (U/L)a | 13 | 46 | 34 | > 0.05 |
| (11–18) | (24.5–61) | (14.5–62.5) | ||
| a | a | a | ||
| ALP (U/L)a | 51 | 77 | 67 | > 0.05 |
| (50–66) | (59–134) | (52–99) | ||
| a | a | a | ||
| Albumin (g/dl)b | 3.87 ± 0.91 | 3.15 ± 0.89 | 2.74 ± 0.91 | < 0.05 |
| a | b | b | ||
| TGF-β1 (ng/ml)b | 7.9 ± 0.62 | 9.27 ± 0.65 | 11.9 ± 1.19 | < 0.05 |
| a | b | c | ||
| PT (second)a | 12 | 16.7 | 16.9 | < 0.05 |
| (11.5–12) | (13–19.15) | (12.5–19.3) | ||
| a | b | b | ||
| PC (%)a | 94 | 63 | 59 | < 0.05 |
| (89.8–98) | (47.6–80) | (43.2–84.5) | ||
| a | b | b | ||
| INRb | 1.14 ± 0.28 | 1.53 ± 0.46 | 1.42 ± 0.32 | < 0.05 |
| a | b | b |
Groups bearing different initials are significantly different from each other at p = 0.05.
a
Data presented as median (25th–75th percentile).
b
Data presented as mean ± SD. Groups bearing same initials are not significantly different from each other at p = 0.05.